マイコプラズマ検査市場：製品・サービス、技術、用途、エンドユーザー別-2025-2030年の世界予測

マイコプラズマ検査市場は、2023年に10億米ドルと評価され、2024年には10億8,000万米ドルに達すると予測され、CAGR 8.29%で成長し、2030年には17億5,000万米ドルに達すると予測されています。

マイコプラズマ検査は、製品の品質と患者の安全性を損なう可能性のある汚染を検出することにより、生物製剤、ワクチン、細胞ベースの療法の安全性と有効性を確保する上で重要な役割を果たしています。その必要性は、医薬品やバイオテクノロジー産業における厳しい規制要件や品質保証基準から生じ、信頼性の高い検査ソリューションへの需要を後押ししています。主なアプリケーションには、細胞培養やワクチン製造があり、汚染はバッチの失敗や多額の金銭的損失につながる可能性があります。最終用途には、製薬会社、研究機関、委託研究機関などが含まれます。市場の成長は、慢性疾患の増加、バイオ医薬品製造の進歩、個別化医療への注目の高まりに大きく影響されています。さらに、PCRベースの手法や検査手順の自動化などの技術的進歩は、潜在的な成長機会をもたらします。次世代シーケンシング（NGS）とポイントオブケア検査における革新は、利害関係者に競争上の優位性を提供することができます。しかし、高度な検査ツールの高コスト、異なるマイコプラズマ種を扱うことの複雑さ、地域間の厳しい規制状況などの課題も残っており、市場拡大の妨げとなる可能性があります。新たな機会を活用するために、企業は費用対効果が高く、迅速で高感度な検出法を開発するための研究開発に投資しなければならないです。バイオテクノロジー企業や研究機関との連携も、技術的進歩の一助となります。未開拓の市場を開拓するための地域拡大への重点的な取り組みと、さまざまな地域にまたがる規制機関への強固なコンプライアンスの維持が鍵となります。全体として、マイコプラズマ検査市場は、その性質上、精度と技術統合に重点を置きながら急速に進化しており、技術革新のための魅力的な空間を提示しています。優先分野には、ユーザーフレンドリーで迅速な検出キットや自動化システムの開発が含まれ、これらは検査プロトコルを根本的に変革し、効率性と信頼性を向上させる可能性があります。これらの分野への競合考察に基づく戦略的投資は、長期的に大きな利益を生み出し、競合優位性を促進する可能性があります。

市場力学：急速に進化するマイコプラズマ検査市場の主要市場インサイトを公開

マイコプラズマ検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • マイコプラズマ関連疾患の増加
  • バイオテクノロジーおよび製薬業界における品質管理需要の高まり
  • 細胞培養やワクチン製造におけるマイコプラズマ検査の重要性の高まり
• 市場抑制要因
  • 高価な診断技術、限られた技術者しか利用できないこと
• 市場機会
  • マイコプラズマ検査におけるAIや機械学習との統合によるデータ解析と結果解釈の強化
  • 高スループット検査と手作業によるエラー削減のための自動化開発
• 市場の課題
  • 進化するマイコプラズマ菌株間で一貫した検査性能を確保すること

ポーターのファイブフォースマイコプラズマ検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：マイコプラズマ検査市場における外部からの影響の把握

外部マクロ環境要因は、マイコプラズマ検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析マイコプラズマ検査市場における競合情勢の把握

マイコプラズマ検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスマイコプラズマ検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、マイコプラズマ検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨マイコプラズマ検査市場における成功への道筋を描く

マイコプラズマ検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • マイコプラズマ関連疾患の蔓延
    • バイオテクノロジーおよび製薬業界における品質管理の需要の高まり
    • 細胞培養とワクチン製造におけるマイコプラズマ検査の重要性の高まり
  • 抑制要因
    • 診断技術が高価で、専門知識が限られている
  • 機会
    • マイコプラズマ検査におけるAIと機械学習の統合により、データ分析と結果の解釈を強化
    • 高スループットテストの自動化と手作業によるエラーの削減の開発
  • 課題
    • 進化するマイコプラズマ株間で一貫した検査性能を確保する
• 市場セグメンテーション分析
  • 迅速かつ正確な臨床結果を得るためのマイコプラズマ検査におけるPCR技術の使用
  • 細胞治療開発のための製薬およびバイオテクノロジー分野でのマイコプラズマ検査の採用増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 マイコプラズマ検査市場：製品・サービス別

• アッセイ、キット、試薬
• 機器
  • DNAシーケンサー
  • ELISAリーダー
  • 蛍光顕微鏡
  • PCRシステム
• サービス
  • 認証および検証サービス
  • コンサルティングサービス
  • テストサービス

第7章 マイコプラズマ検査市場：技術別

• 直接DNA染色
• 酵素免疫測定法
• 核酸検査
• ポリメラーゼ連鎖反応

第8章 マイコプラズマ検査市場：用途別

• 細胞株試験
• 医薬品の発見と開発
• ウイルス検査

第9章 マイコプラズマ検査市場：エンドユーザー別

• 学術調査機関
• 細胞バンクと研究室
• 契約調査機関
• 製薬・バイオテクノロジー企業

第10章 南北アメリカのマイコプラズマ検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のマイコプラズマ検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのマイコプラズマ検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • AnaBioTecとbioMerieuxは、高度なNATテクノロジーと包括的な検証サービスでマイコプラズマ検査に革命を起こします
  • QIAGEN、安全性試験ソリューションの精度と効率を高める新しいQIAcuityデジタルPCRキットを発売
• 戦略分析と提言

企業一覧

• Abcam plc
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• BioFire Diagnostics, Inc.
• Bionique Testing Laboratories, Inc.
• Charles River Laboratories International, Inc.
• Creative Bioarray
• Eurofins Scientific SE
• F. Hoffmann-La Roche AG
• Genecopoeia, Inc.
• InvivoGen
• Lonza Group Ltd.
• Merck KGaA
• Meridian Bioscience, Inc.
• Minerva Biolabs GmbH
• MP Biomedicals, LLC
• Mycoplasma Experience Limited
• Nelson Laboratories Fairfield, Inc.
• Norgen Biotek Corporation
• Promocell GmbH
• Savyon Diagnostics
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
• Wuxi AppTec

LIST OF FIGURES

• FIGURE 1. MYCOPLASMA TESTING MARKET RESEARCH PROCESS
• FIGURE 2. MYCOPLASMA TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MYCOPLASMA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. MYCOPLASMA TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. MYCOPLASMA TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MYCOPLASMA TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MYCOPLASMA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MYCOPLASMA TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DNA SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ELISA READERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY FLUORESCENT MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CERTIFICATION & VALIDATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DIRECT DNA STAINING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY NUCLEIC ACID TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CELL LINE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY VIRUS TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CELL BANKS & LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. CANADA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 54. CANADA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 55. CANADA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 56. CANADA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 57. CANADA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. CANADA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. CHINA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 86. CHINA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 87. CHINA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 88. CHINA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 89. CHINA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. CHINA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. INDIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 92. INDIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 93. INDIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 94. INDIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 95. INDIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. INDIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. ITALY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 195. ITALY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 196. ITALY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 197. ITALY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 198. ITALY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. ITALY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. POLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 219. POLAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 220. POLAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 221. POLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 222. POLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. POLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. QATAR MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 225. QATAR MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 226. QATAR MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 227. QATAR MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 228. QATAR MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. QATAR MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 284. MYCOPLASMA TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 285. MYCOPLASMA TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Mycoplasma Testing Market was valued at USD 1.00 billion in 2023, expected to reach USD 1.08 billion in 2024, and is projected to grow at a CAGR of 8.29%, to USD 1.75 billion by 2030.

Mycoplasma testing plays a crucial role in ensuring the safety and efficacy of biologics, vaccines, and cell-based therapies by detecting contamination, which could compromise product quality and patient safety. Necessity arises from stringent regulatory requirements and quality assurance standards in pharmaceuticals and biotechnology industries, propelling demand for reliable testing solutions. Key applications include cell culture and vaccine production, where any contamination can lead to batch failures and substantial financial loss. End-use scope encompasses pharmaceutical companies, research institutes, and contract research organizations. Market growth is predominantly influenced by the increasing prevalence of chronic diseases, advancements in biopharmaceutical production, and a rising focus on personalized medicine. Furthermore, technological advancements such as PCR-based methods and automation in testing procedures present potential opportunities for growth. Innovations in next-generation sequencing (NGS) and point-of-care testing can provide competitive advantages to stakeholders. However, challenges persist, including high costs of advanced testing tools, the complexity of dealing with different mycoplasma species, and stringent regulatory landscapes across regions, which may hinder market expansion. To leverage emerging opportunities, businesses must invest in R&D to develop cost-effective, rapid, and highly sensitive detection methods. Collaboration with biotechnology companies and research organizations can also aid in technological advancements. A focused effort on regional expansion to tap into underpenetrated markets and maintaining robust compliance with regulatory bodies across different geographies will be key. Overall, the mycoplasma testing market by nature is rapidly evolving, with an emphasis on precision and technological integration, presenting an attractive space for innovation. Priority areas include the development of user-friendly, rapid detection kits and automated systems, which could radically transform testing protocols and improve efficiency and reliability. Insight-driven strategic investment in these areas could harness significant long-term gains and drive the competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mycoplasma Testing Market

The Mycoplasma Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of mycoplasma related diseases
  • Rising demand for quality control in biotechnology and pharmaceutical industry
  • Growing importance of mycoplasma testings in cell culture and vaccine production
• Market Restraints
  • Expensive diagnostics technique and limited availability of technical experties
• Market Opportunities
  • Integration with AI and machine learning in mycoplasma testings for enhancements in data analysis and result interpretation
  • Development of automation for high throughput testings and reducing manual errors
• Market Challenges
  • Ensuring consistent performance of test among evolving mycoplasma strains

Porter's Five Forces: A Strategic Tool for Navigating the Mycoplasma Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mycoplasma Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mycoplasma Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mycoplasma Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mycoplasma Testing Market

A detailed market share analysis in the Mycoplasma Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mycoplasma Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mycoplasma Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mycoplasma Testing Market

A strategic analysis of the Mycoplasma Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mycoplasma Testing Market, highlighting leading vendors and their innovative profiles. These include Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioFire Diagnostics, Inc., Bionique Testing Laboratories, Inc., Charles River Laboratories International, Inc., Creative Bioarray, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Genecopoeia, Inc., InvivoGen, Lonza Group Ltd., Merck KGaA, Meridian Bioscience, Inc., Minerva Biolabs GmbH, MP Biomedicals, LLC, Mycoplasma Experience Limited, Nelson Laboratories Fairfield, Inc., Norgen Biotek Corporation, Promocell GmbH, Savyon Diagnostics, Takara Bio Inc., Thermo Fisher Scientific, Inc., and Wuxi AppTec.

Market Segmentation & Coverage

This research report categorizes the Mycoplasma Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Service, market is studied across Assays, Kits, & Reagents, Instruments, and Services. The Instruments is further studied across DNA Sequencers, ELISA Readers, Fluorescent Microscopes, and PCR Systems. The Services is further studied across Certification & Validation Services, Consulting Services, and Testing Services.
• Based on Technique, market is studied across Direct DNA Staining, Enzyme-Linked Immunosorbent Assay, Nucleic Acid Testing, and Polymerase Chain Reaction.
• Based on Application, market is studied across Cell Line Testing, Drug Discovery & Development, and Virus Testing.
• Based on End-User, market is studied across Academic & Research Institutes, Cell Banks & Laboratories, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of mycoplasma related diseases
    • 5.1.1.2. Rising demand for quality control in biotechnology and pharmaceutical industry
    • 5.1.1.3. Growing importance of mycoplasma testings in cell culture and vaccine production
  • 5.1.2. Restraints
    • 5.1.2.1. Expensive diagnostics technique and limited availability of technical experties
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration with AI and machine learning in mycoplasma testings for enhancements in data analysis and result interpretation
    • 5.1.3.2. Development of automation for high throughput testings and reducing manual errors
  • 5.1.4. Challenges
    • 5.1.4.1. Ensuring consistent performance of test among evolving mycoplasma strains
• 5.2. Market Segmentation Analysis
  • 5.2.1. Usage of PCR techniques in mycoplasma testings for rapid and precise clinical results

• 5.2.2. Rising adoption of mycoplasma testings in pharmaceutical & biotechnology sectors for cell therapy development

• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Mycoplasma Testing Market, by Product & Service

• 6.1. Introduction
• 6.2. Assays, Kits, & Reagents
• 6.3. Instruments
  • 6.3.1. DNA Sequencers
  • 6.3.2. ELISA Readers
  • 6.3.3. Fluorescent Microscopes
  • 6.3.4. PCR Systems
• 6.4. Services
  • 6.4.1. Certification & Validation Services
  • 6.4.2. Consulting Services
  • 6.4.3. Testing Services

7. Mycoplasma Testing Market, by Technique

• 7.1. Introduction
• 7.2. Direct DNA Staining
• 7.3. Enzyme-Linked Immunosorbent Assay
• 7.4. Nucleic Acid Testing
• 7.5. Polymerase Chain Reaction

8. Mycoplasma Testing Market, by Application

• 8.1. Introduction
• 8.2. Cell Line Testing
• 8.3. Drug Discovery & Development
• 8.4. Virus Testing

9. Mycoplasma Testing Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Cell Banks & Laboratories
• 9.4. Contract Research Organizations
• 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Mycoplasma Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Mycoplasma Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Mycoplasma Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. AnaBioTec and bioMerieux revolutionize mycoplasma testing with advanced NAT technologies and comprehensive validation services
  • 13.3.2. QIAGEN launches new QIAcuity digital PCR kits, enhancing accuracy and efficiency of safety testing solutions
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam plc
• 2. Agilent Technologies, Inc.
• 3. Bio-Rad Laboratories, Inc.
• 4. BioFire Diagnostics, Inc.
• 5. Bionique Testing Laboratories, Inc.
• 6. Charles River Laboratories International, Inc.
• 7. Creative Bioarray
• 8. Eurofins Scientific SE
• 9. F. Hoffmann-La Roche AG
• 10. Genecopoeia, Inc.
• 11. InvivoGen
• 12. Lonza Group Ltd.
• 13. Merck KGaA
• 14. Meridian Bioscience, Inc.
• 15. Minerva Biolabs GmbH
• 16. MP Biomedicals, LLC
• 17. Mycoplasma Experience Limited
• 18. Nelson Laboratories Fairfield, Inc.
• 19. Norgen Biotek Corporation
• 20. Promocell GmbH
• 21. Savyon Diagnostics
• 22. Takara Bio Inc.
• 23. Thermo Fisher Scientific, Inc.
• 24. Wuxi AppTec